Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Boutron

Showing results (271-280 of 291) with videos related to

Pageof 30
Sort By:
JAMA|June 21, 2021
Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 StatementAaron M Orkin, Peter J Gill, Davina Ghersi, et al.
BMJ (Clinical Research Ed.)|October 14, 2016
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventionsJonathan Ac Sterne, Miguel A Hernán, Barnaby C Reeves, et al.
BMJ Open|August 10, 2013
The Scleroderma Patient-centered Intervention Network (SPIN) Cohort: protocol for a cohort multiple randomised controlled trial (cmRCT) design to support trials of psychosocial and rehabilitation interventions in a rare disease contextLinda Kwakkenbos, Lisa R Jewett, Murray Baron, et al.
Ewha Medical Journal|July 31, 2025
CONSORT 2025 statement: updated guideline for reporting randomized trials: a Korean translationSally Hopewell, An-Wen Chan, Gary S Collins, et al.
Vaccine|September 17, 2023
Protocol for a living evidence synthesis on variants of concern and COVID-19 vaccine effectivenessNicole Shaver, Melanie Katz, Gideon Darko Asamoah, et al.
JAMA|April 14, 2025
CONSORT 2025 Statement: Updated Guideline for Reporting Randomized TrialsSally Hopewell, An-Wen Chan, Gary S Collins, et al.
Lancet (London, England)|April 17, 2025
CONSORT 2025 statement: updated guideline for reporting randomised trialsSally Hopewell, An-Wen Chan, Gary S Collins, et al.
Plos Medicine|April 14, 2025
CONSORT 2025 statement: Updated guideline for reporting randomised trialsSally Hopewell, An-Wen Chan, Gary S Collins, et al.
Nature Medicine|April 14, 2025
CONSORT 2025 statement: updated guideline for reporting randomized trialsSally Hopewell, An-Wen Chan, Gary S Collins, et al.
Trials|November 28, 2021
The Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program: protocol for a two-arm parallel partially nested randomized controlled feasibility trial with progression to full-scale trialJulia Nordlund, Richard S Henry, Linda Kwakkenbos, et al.
Pageof 30

Showing results (271-280 of 291) with videos related to

Sort By:
Pageof 30
JAMA|June 21, 2021
Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 StatementAaron M Orkin, Peter J Gill, Davina Ghersi, et al.
BMJ (Clinical Research Ed.)|October 14, 2016
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventionsJonathan Ac Sterne, Miguel A Hernán, Barnaby C Reeves, et al.
BMJ Open|August 10, 2013
The Scleroderma Patient-centered Intervention Network (SPIN) Cohort: protocol for a cohort multiple randomised controlled trial (cmRCT) design to support trials of psychosocial and rehabilitation interventions in a rare disease contextLinda Kwakkenbos, Lisa R Jewett, Murray Baron, et al.
Ewha Medical Journal|July 31, 2025
CONSORT 2025 statement: updated guideline for reporting randomized trials: a Korean translationSally Hopewell, An-Wen Chan, Gary S Collins, et al.
Vaccine|September 17, 2023
Protocol for a living evidence synthesis on variants of concern and COVID-19 vaccine effectivenessNicole Shaver, Melanie Katz, Gideon Darko Asamoah, et al.
JAMA|April 14, 2025
CONSORT 2025 Statement: Updated Guideline for Reporting Randomized TrialsSally Hopewell, An-Wen Chan, Gary S Collins, et al.
Lancet (London, England)|April 17, 2025
CONSORT 2025 statement: updated guideline for reporting randomised trialsSally Hopewell, An-Wen Chan, Gary S Collins, et al.
Plos Medicine|April 14, 2025
CONSORT 2025 statement: Updated guideline for reporting randomised trialsSally Hopewell, An-Wen Chan, Gary S Collins, et al.
Nature Medicine|April 14, 2025
CONSORT 2025 statement: updated guideline for reporting randomized trialsSally Hopewell, An-Wen Chan, Gary S Collins, et al.
Trials|November 28, 2021
The Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program: protocol for a two-arm parallel partially nested randomized controlled feasibility trial with progression to full-scale trialJulia Nordlund, Richard S Henry, Linda Kwakkenbos, et al.
Pageof 30